menu
faruqi and faruqi novavax recent update the securities litigation attorney
faruqi and faruqi novavax recent update the securities litigation attorney
faruqi and faruqi novavax recent update the securities litigation attorney

Partners in Securities Litigation James (Josh) Wilson Encourages Investors who have suffered losses of more than $200,000 in Novavax to Contact him directly To Discuss Their Options

New York, faruqi and faruqi lawyers New York--(Newsfile Corp. - - October 24, 2021) (Newsfile Corp. - October 24, Faruqi and Faruqi 2021) Faruqi & Faruqi, LLP, a leading national securities law firm is currently investigating allegations against Novavax ("Novavax, Inc." ("Novavax, Inc.") or "Company") (NASDAQ: NVAX).

If you've suffered losses that exceed $200,000 in Novavax options or stock and you would like to talk about your rights as a legal person, please call Faruqi & Faruqi partner Josh Wilson directly at 877-247-492 or 212-983-9330 (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/NVAX.

Faruqi & Faruqi is a prominent minority and woman-owned national securities law firm , with branches across New York, Delaware, Pennsylvania, California and Georgia.

On October 19, 2021, the day after the market closed, Politico published an article that was titled "'They Rushed the Process': Vaccine Maker's woes hamper global inoculation campaign", in which they stated the "manufacturing problems are jeopardizing billions of doses earmarked for poor and middle-income countries." The article further stated it was "[a]lthough Novavax recently attested to some of its analytics and testing issues ... the company's